Cryoablation and Cementoplasty for local Control of Osteosarcoma Management (CAPCOM)
Currently EnrollingThis clinical trial is evaluating a new, minimally invasive treatment for dogs with osteosarcoma, a common and aggressive bone cancer. This innovative approach, called Cryoablation and Cementoplasty for local Control of Osteosarcoma Management (CAPCOM), offers a limb-sparing alternative for dogs who may not be good candidates for amputation due to other health issues.
The CAPCOM procedure involves two key steps:
- Cryoablation: Small probes are inserted directly into the tumor to freeze cancer cells to -40°C, causing them to burst and die. This technique has been used successfully in human oncology for decades to provide quick, long-lasting pain control and improve quality of life.
- Cementoplasty: After the tumor is destroyed, medical-grade bone cement is injected into the cavity to strengthen the bone and prevent future fractures.
Our Goal
The purpose of this study is to assess the safety and effectiveness of the CAPCOM procedure as a local tumor control for dogs with osteosarcoma. We will be closely monitoring outcomes such as pain relief, quality of life, complication rates, and cancer progression.
Eligibility Requirements
We are initially enrolling 6 dogs in this study who meet the following criteria:
- Diagnosis of osteosarcoma in the distal radius.
- Tumor size no greater than 6cm in diameter (width, measured medial to lateral).
- Otherwise in good health and deemed safe for anesthesia and surgery based on a physical exam, bloodwork, and chest x-rays.
What the Study Covers
The study is designed to significantly reduce the financial burden on owners while providing access to this innovative treatment.
Costs Covered by the Study:
- Physical exams and diagnostics, including CT scans (a $3,000 value per scan).
- Up to $5,000 of the surgical costs.
- Up to $3,000 for the treatment of any unexpected side effects related to the study protocol.
Costs You Are Responsible For:
- Pre-enrollment testing (bloodwork, cytology of tumor, thoracic radiographs).
- A portion of the total surgical costs, expected to be between $5,000 – $7,000.
- Costs for any treatments elected outside of the study requirements (e.g., chemotherapy).
Follow-Up Care
Following the procedure, your dog will have a total of 6 follow-up visits over 11 months for monitoring. This will include physical exams, radiographs of the lungs and tumor site, and repeat CT scans of the treated bone at 6 and 11 months.
Get in Touch
We are committed to providing hope and advanced care options for pets with cancer. If you have a patient that you believe would be a good candidate for the CAPCOM trial, please contact our team to learn more.
For all inquiries and referrals, please email: bonecancer@ethosvet.com
Participation in a clinical study is subject to medical eligibility and availability requirements. Financial incentives, including potential stipends or reimbursements, are contingent upon meeting study criteria and completing required visits or activities. Additional terms and conditions may apply.